No Data
No Data
Top Gap Ups and Downs on Friday: ADBE, BABA, TTE and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
Top Gap Ups and Downs on Thursday: AVGO, TSLA, TM and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin) Insights & Forecast 2024-2028, Featuring CSL, Grifols, Takeda Pharmaceutical, Octapharma, Kedrion & ADMA Biologics - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin): Insights & Forecast (2024-2028)" report has been added to ResearchAndMarkets.com's o
Express News | Takeda Expands Partnership With Partners In Health To Address Social Determinants Of Health And Improve Access To Care In Massachusetts
Notice Concerning Issuance of New Shares and Disposal of Treasury Shares Under the Long-Term Incentive Plan for Company Group Employees Outside of Japan
OSAKA, Japan, June 11, 2024 – Takeda Pharmaceutical Company Limited ("Company") today announced that it decided on the issuance of new shares and disposal of treasury shares under the Long Term Incent
Takeda Pharmaceutical Prices Second Hybrid Bonds for 460 Billion Yen
Takeda Pharmaceutical (TYO:4502) announced the pricing of its 2nd Hybrid Bonds with a total principal amount of 460 billion yen, according to its filing last Friday. The proceeds will be used to redee
TrytosaveabitOP : AC Immune Eligible for $2.1B in Potential Milestones
74137893 : too fast to catch
TrytosaveabitOP 74137893: IMO it’s not done! NFA
YYDW : There was another sudden surge like this; you just get covered when you enter